Insider Transactions in Q1 2022 at Poseida Therapeutics, Inc. (PSTX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2022
|
Kerry D. Ingalls Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+5.17%
|
$9,000
$3.98 P/Share
|
|
Mar 01
2022
|
Brent Warner President, Gene Therapy |
BUY
Grant, award, or other acquisition
|
Direct |
307,881
+50.0%
|
-
|
|
Mar 01
2022
|
Matthew A. Spear Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+30.96%
|
-
|
|
Mar 01
2022
|
Johanna Mylet Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+37.25%
|
-
|
|
Mar 01
2022
|
Kerry D. Ingalls Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+49.02%
|
-
|
|
Mar 01
2022
|
Harry J Leonhardt GC & Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Feb 01
2022
|
Eric Ostertag Director |
BUY
Grant, award, or other acquisition
|
Direct |
89,500
+11.44%
|
-
|
|
Feb 01
2022
|
Mark J Gergen Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
357,200
+50.0%
|
-
|